Aspergillosis

  • Daraprim 2020 report

    Daraprim 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Nurtec ODT 2020 report

    Nurtec ODT 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 22 Pages The 5 Key Questions Addressed by this...

  • Cresemba 2019 report

    Cresemba 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Noxafil 2019 report

    Noxafil 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Cresemba 2018 report

    Cresemba 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Noxafil 2018 report

    Noxafil 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Cresemba 2017 report

    Cresemba 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Noxafil 2017 report

    Noxafil 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Cresemba 2016 report

    Cresemba 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 30 Pages The 5 Key Questions Addressed by this Report:...

  • Noxafil 2016 report

    Noxafil 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Cresemba 2015 report

    Cresemba 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 31 Pages The 5 Key Questions Addressed by this...

  • Noxafil 2015 report

    Noxafil 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...